Journal of Vaccines and Immunology Submit Manuscript

    Introduction

    • Volume/IssueClick here
    • Review ProcessDouble Blind
      • Publication lead time3 - 4 weeks
      • Indexing statusYes; Purview
      • Manuscript Processing ChargesClick here
      • Submission ChargesYes
      • Waiver policy for APCYes
      • Language of Full TextEnglish
      • Full-text formats availablePDF, HTML
    • Show +
    • Articles digitally archived in PORTICO
    • Permanent article identifierDOI (Digital Object Identifier) We provide DOI to all published papers to facilitate higher citation and classification of articles.
      Peertechz Publisher ID: 10.17352
    • Type of LicenseCreative Commons
      • Open AccessYes; Policy
      • Does the author retain unrestricted copyright?Yes
      • Does the author retain publishing rights?Yes
    • Show +

    Editorial Board

    David Allen Reardon
    Professor
    Cancer Institute
    Harvard Cancer Center
    USA
    david_reardon@dfci.harvard.edu
    JVI

    Research Interest: Innovative Clinical Therapeutic Agents To Improve Cure Rates In Patients With Brain And Spinal Tumors, With Particular Focus On Immunotherapeutics As Well As Molecular-Targeting Agents, Anti-Angiogenic Reagents, Cytotoxins And Other Biologically-Based Therapies.

    More Info.
    Mingsheng Cai
    Associate professor
    Depaertment of Pathogenic Biology and Immunology
    Guang zhou Medical University
    China
    mingshengcai@hotmail.com
    JVI

    Research Interest: Molecular mechanisms of immune evasion of EBV and HSV-1. Molecular mechanisms of EBV and HSV-1 infection and its interaction with the host. Mechanisms of pathogenesis of EBV and HSV-1 infection.

    Published Papers:

    1.    Representative papers published after work

    1)    Li ML, Chen T, Wang P, Zou XM, Xu Z, Wang YF, Chen DX, Peng T, Cai MS(*). Characterization of the nucleocytoplasmic transport mechanisms of Epstein-Barr virus BFLF2. Cellular Physiology and Biochemistry, 2018, Accept. (SCI, IF=5.5)

    2)    Cai MS, Liao ZM, Chen T, Wang P, Zou XM, Wang YF, Xu Z, Jiang S, Huang JL, Chen DX, Peng T, Hong GD, Li ML(*). Characterization of the subcellular localization of Epstein-Barr virus encoded proteins in live cells. Oncotarget, 2017, 8(41), 70006-70034. (SCI, IF=5.168)

    http://www.impactjournals.com/oncotarget/index.php?journal=oncotarget&page=article&op=view&path[]=19549&author-preview=f31

    3)    Cai MS, Li ML, Wang KZ, Wang S, Lu Q, Yan JH, Mossman KL, Lin RT, Zheng CF(*). The herpes simplex virus 1-encoded envelope glycoprotein B activates NF-κB through the Toll-like receptor 2 and MyD88/TRAF6-dependent signaling pathway. Plos One, 2013, 8(1), e54586. (SCI, IF=3.534)
    http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0054586

    4)    Cai MS, Deng SX, Li ML(*). Comparison of the immune responses in BALB/c Mice following immunization with DNA-based and live attenuated vaccines delivered via different routes. Vaccine, 2013, 31(9),1353-1356. (SCI, IF=3.485)
    https://linkinghub.elsevier.com/retrieve/pii/S0264-410X(12)01308-4

    5)    Cai MS, Jiang S, Zeng ZC, Li XW, Mo CC, Yang YJ, Chen CK, Xie PP, Bian Y, Wang JL, Huang JL, Chen DX, Peng T, Li ML(*). Probing the nuclear import signal and nuclear transport molecular determinants of PRV ICP22. Cell & Bioscience, 2016, 6: 3. (SCI, IF=3.294)
    https://cellandbioscience.biomedcentral.com/articles/10.1186/s13578-016-0069-7

    6)    Cai MS, Jiang S, Li XW, Zeng ZC, Li ML(*). Characterization of the nuclear import mechanisms of HSV-1 UL31. Biological Chemistry. 2016, 397(6): 555-561. (SCI, IF=3.273)
    https://www.degruyter.com/doi/10.1515/hsz-2015-0299

    7)    Cai MS, Huang ZB, Liao ZM, Chen T, Wang P, Jiang S, Chen DX, Peng T, Bian Y, Hong GD, Yang H, Zeng ZC, Li XW, Li ML(*). Characterization of the subcellular localization and nuclear import molecular mechanisms of herpes simplex virus 1 UL2. Biological Chemistry. 2017, 398(4): 509-517. (SCI, IF=3.273)
    https://www.degruyter.com/doi/10.1515/hsz-2016-0268 

    8)    Cai MS, Li ML, Zheng CF(*). Herpesviral infection and Toll-like receptor 2. Protein & Cell, 2012, 3(8), 590-601. (SCI, IF=3.22)

    https://dx.doi.org/10.1007/s13238-012-2059-9

    9)    Li ML, Jiang S, Mo CC, Wang JL, Huang JL, Zeng ZC, Li XW, Chen CK, Yang YJ, Peng T, Cai MS(*). Identification of molecular determinants for the nuclear import of pseudorabies virus UL31. Archives of Biochemistry and Biophysics, 2015, 587, 12-7. (SCI, IF=2.807)
    https://linkinghub.elsevier.com/retrieve/pii/S0003-9861(15)30075-8

    10)    Li ML, Jiang S, Wang JL, Mo CC, Zeng ZC, Yang YJ, Chen CK, Li XW, Cui W, Huang JL, Peng T, Cai MS(*). Characterization of the nuclear import and export signals of pseudorabies virus UL31. Archives of Virology, 2015, 160, 2591-2594. (SCI, IF=2.255)
    https://link.springer.com/article/10.1007/s00705-015-2527-7

    11)    Cai MS, Chen DX, Zeng ZC, Yang H, Jiang S, Li XW, Mai JY, Peng T, Li ML*. Characterization of the nuclear import signal of herpes simplex virus 1 UL31. Archives of Virology, 2016, 161(9):2379-2385. (SCI, IF=2.058)
    https://dx.doi.org/10.1007/s00705-016-2910-z

    12)    Li ML, Cui W, Mo CC, Wang JL, Zhao ZY, Cai MS(*). Cloning, expression, purification, antiserum preparation and its characteristics of the truncated UL6 protein of herpes simplex virus 1. Molecular Biology Reports, 2014, 41(9), 5997-6002. (SCI, IF=2.024)
    https://dx.doi.org/10.1007/s11033-014-3477-y

    2.    Representative papers published at the time of Ph.D. candidate
    13)    Cai MS, Wang S, Long J, Zheng CF(*). Probing of the nuclear import and export signals and subcellular transport mechanism of varicella-zoster virus tegument protein open reading frame 10. Medical Microbiology and Immunology, 2012, 201(1), 103-111. (SCI, IF=3.545)
    https://link.springer.com/article/10.1007/s00430-011-0211-4

    14)    Cai MS, Wang S, Xing JJ, Zheng CF(*). Characterization of the nuclear import and export signals, and subcellular transport mechanism of varicella-zoster virus ORF9. Journal of General Virology, 2011, 92(Pt 3), 621-626. (SCI, IF=3.363)
    http://jgv.microbiologyresearch.org/content/journal/jgv/10.1099/vir.0.027029-0#tab2

    15)    Li ML, Wang S, Cai MS, Zheng CF(*). Identification of nuclear and nucleolar localization signals of PRV early protein UL54 reveals that its nuclear targeting is required for efficient production of virus. Journal of virology, 2011, 85, 10239–10251. (SCI, IF=5.402)
    http://jvi.asm.org/content/85/19/10239.long

    16)    Wang L, Li ML, Cai MS, Xing JJ, Wang S, Zheng CF(*). A PY-nuclear localization signal is required for nuclear accumulation of HCMV UL79 protein. Medical Microbiology and Immunology, 2012, 201(3),381-387. (SCI, IF=3.545)

    https://link.springer.com/article/10.1007/s00430-012-0243-4

    17)    Li ML, Wang S, Cai MS, Guo H, Zheng CF(*). Characterization of molecular determinants for nucleocytoplasmic shuttling of PRV UL54. Virology, 2011, 417, 385-417. (SCI, IF=3.351)
    https://linkinghub.elsevier.com/retrieve/pii/S0042-6822(11)00268-6

    3.    Representative papers published at the time of M.Sc. candidate
    18)    Cai MS, Cheng AC(*), Wang MS, Chen WP, Zhang X, Zheng SX, Pu Y, Lou KP, Zhang Y, Sun L, Wang LL, Zhu DK, Luo QH, Chen XY. Characterization of the duck plague virus UL35 gene. Intervirology, 2010, 53(6), 408-416. (SCI, IF=1.756)
    https://www.karger.com/?DOI=10.1159/000317291

    19)    Cai MS, Cheng AC (*), Wang MS, Zhao LC, Zhu DK, Luo QH, Liu F, Chen XY. His6-tagged UL35 protein of duck plague virus: expression, purification, and production of polyclonal antibody. Intervirology, 2009, 52(3),141-151. (SCI, IF=1.106)
    https://www.karger.com/?DOI=10.1159/000221833

    20)    Cai MS, Cheng AC (*), Wang MS, Zhao LC, Zhu DK, Luo QH, Liu F, Chen XY. Characterization of synonymous codon usage bias in the duck plague virus UL35 gene. Intervirology, 2009, 52(5), 266-278. (SCI, IF=1.106)
    https://www.karger.com/Article/Abstract/231992



    More Info.
    Liping Jin
    Department of Obstetrics and Gynecology
    Fudan University Shanghai Medical College
    China
    jinlp01@163.com
    JVI

    Research Interest: The keywords of my research interest: Reproductive immunology, Thymic stromal lymphopoietin, The costimulatory signal, Trophoblast, Gamma-delta T cell, CD4+CD25bright regulatory T cell, Pregnancy, Miscarriage, The maternal-fetal immune.

    More Info.
    Li Junwei
    Texas Tech University
    USA
    junwei.li@ttuhsc.edu
    JVI

    Research Interest: My Research Focus on Design Universal and Live Attenuated Influenza Vaccine by using Novel Methods, and Testingthese New Generation Vaccine Candidates in Humanized Mice and Ferrets. As Well, We would like to explore the Mechanism of Cross-Protection induced by live Attenuated Influenza against seasonal and Pandemic Influenza Viruses. Our Results Suggested That Activation of T cell Is Crucial for the cross Protection Stimulated By vaccination With Live Attenuated Influenza Vaccine. In Future Research, We Will Focus on B Cell Development Stimulated by Vaccination with Live Attenuated Influenza vaccine. To Facilitate The Development Of More Effective Vaccines, We Are Also Researching: The Effect Of Current Vaccination Programs On The Epidemiological Changes Of Respiratory Pathogens (Strain Replacement And Antigenic Variation); How People Respond To Infections Or Vaccinations At The Cellular And Molecular Levels (B Cell, T Cell, And Gene expression Levels) identification of New Protective Antigens Through Genomic And Proteomic Approaches.

    More Info.
    Chiara Cadeddu
    Institute of Public Health
    Catholic University of Sacred Heart
    Italy
    chiaracadeddu@yahoo.it
    JVI

    Research Interest: Public Health and Health Technology Assessment, particularly for vaccines. 

    More Info.
    Manmohan Singh
    Head
    Global Drug Product Development
    Technical Development Novartis Vaccines
    USA
    manmohan.singh@novartis.com
    JVI

    Research Interest: He focused on developing novel adjuvants and vaccine delivery systems for prophylactic vaccination along with rational design of new vaccine formulations for Novartis discovery projects.

    More Info.
    Bingyun Li
    Professor
    Department of Orthopaedics
    West Virginia University
    USA
    bili@hsc.wvu.edu
    JVI

    Research Interest: Nanomedicine, Controlled/Targeted Drug Delivery, Toxicology, Pharmacology, Cellular Interaction, Nanofilms and Microcapsules, Biomimetic, Microbiology, Immunology.

    More Info.
    Aneta Nitsch-Osuch
    Associate Professor
    Department of Family Medicine
    Warsaw Medical University
    Poland
    anitsch@wum.edu.pl
    JVI

    Research Interest: A specialist in pediatrics and epidemiology.

    More Info.
    Yu-Chen Hu
    Department of Chemical Engineering
    National Tsing Hua University
    Taiwan
    ychu@mx.nthu.edu.tw
    JVI

    Research Interest: Gene therapy, Cell and tissue engineering, Vaccine development, Biomaterials, Synthetic biology and biomass, Nanobiotechnology.

    More Info.
    Debre Patrice
    Professor
    Pierre-and-Marie-Curie University
    France
    patrice.debre@psl.aphp.fr
    JVI

    Research Interest: They relate to functions within Ministry of research (head of mission of the Life Sciences), CNRS (medical advisor for the life sciences), INSERM, ANRS, advisor for clinical Research, and for International Affairs APHP/public hospitals of Paris.

    More Info.
    Magda M S C Sampaio
    Professor of Pediatrics
    Universidade de Sao Paulo
    Brazil
    magdascs@usp.br
    JVI

    Research Interest: Pediatric Immunology: Primary Immunodeficiencies (particularly their autoimmune manifestations), Early-onset Autoimmunity, Human Thymus, Mother-Infant Immunological Relationships (focusing Placental and Milk Antibody Transfer).

    More Info.
    Wayne Grant Carter
    Division of Medical Sciences & Graduate Entry Medicine
    University of Nottingham
    UK
    Wayne.Carter@nottingham.ac.uk
    JVI

    Research Interest: Research interests are varied and include detection and utilisation of novel biomarkers of toxicological exposure.

    More Info.
    Jing Wang
    Associate Professor
    Institute of Oceanology
    China
    jingwang@qdio.ac.cn
    JVI

    Research Interest: The structure of sulfated polysaccharides extracts from seaweeds. The activity of sulfated polysaccharides such as nephrophaty and Parkinsion Disease. The comprehensive utilization of seaweeds especially Saccharina japonica.

    More Info.
    Robert Amato
    Professor and Director
    Department of Oncology
    USA
    Robert.Amato@uth.tmc.edu
    JVI

    Research Interest: Genitourinary Cancer

    More Info.
    Salvatore Chirumbolo
    Professor
    Department of Pathology and Diagnostics
    University of Verona
    Italy
    salvatore.chirumbolo@univr.it
    JVI

    Research Interest: Allergy test in clinical diagnosis, Immunotherapy and in vitro cell assay, Anti-inflammatory properties of natural compounds, Allergy and vaccination, Basophil activation tests.

    More Info.
    View more
    mendeley

    Post-vaccinal reactions following vaccination with the COVID-19 vaccine after first and second dose

    DOI Logo 10.17352/jvi.000060

    Published On: March 05, 2024 | Pages: 006 - 010

    Author(s): Velina Stoeva*, Rosen Mihaylov, Blagovesta Pencheva and Antoineta Mihova

    ORCID Logo  0000-0002-6239-4418

    Abstract View Full Article View
    mendeley

    Considerations for improving future pandemic responses

    DOI Logo 10.17352/jvi.000059

    Published On: February 08, 2024 | Pages: 001 - 005

    Author(s): Mikolaj Raszek*, David Cowley and Alberto Rubio-Casillas

    ORCID Logo  0009-0003-5755-3415

    Abstract View Full Article View
    mendeley

    Evaluation of Anti-SARS-CoV-2 IgG antibody response following COVISHEILD vaccination: A comparison between previously infected and non-infected cohorts

    DOI Logo 10.17352/jvi.000058

    Published On: August 19, 2023 | Pages: 030 - 036

    Author(s): Md Shakeel Ahmed*, Md Zakir Hossain, Md Mamunur Rashid, Istiak Ahmad, Md Zahirul Islam, Meherab Hossain and Hasan Rabbi

    ORCID Logo  0000-0002-3405-2146

    Abstract View Full Article View
    mendeley

    Dietary intervention in enhancing immunity of cancer patients

    DOI Logo 10.17352/jvi.000057

    Published On: August 09, 2023 | Pages: 024 - 029

    Author(s): Dietary intervention in enhancing immunity of cancer patients

    ORCID Logo  0000-0001-8856-3681

    Abstract View Full Article View
    mendeley

    Percutaneous Patent Ductus Arteriosus (PDA) closure: When and how to close Coil VS Occluder “step by step” cases report

    DOI Logo 10.17352/jvi.000056

    Published On: March 22, 2023 | Pages: 015 - 023

    Author(s): Nassime Zaoui*, Amina Boukabous, Nabil Irid, Katia Babou and Sabrina Benamara
    Abstract View Full Article View
    mendeley

    Study of adverse events following 2018 sub-national yellow fever vaccination in Ghana

    DOI Logo 10.17352/jvi.000055

    Published On: February 25, 2023 | Pages: 006 - 014

    Author(s): Douglas Adu-Fokuo, Feng Cheng*, Emily Yin and Elizabeth Giwa
    Abstract View Full Article View
    mendeley

    Alopecia areata

    DOI Logo 10.17352/jvi.000054

    Published On: February 21, 2023 | Pages: 001 - 005

    Author(s): Chieh Chen*

    ORCID Logo  0000-0001-5784-9855

    Abstract View Full Article View
    mendeley

    Characterization of enterotoxigenic Escherichia coli heat-labile toxin (LT) double mutant LTA72R/R192G as a Nontoxic and Effective Mucosal Adjuvant

    DOI Logo 10.17352/jvi.000053

    Published On: October 26, 2022 | Pages: 033 - 039

    Author(s): Li Ben-Qiang, Tao Jie, Cheng Jing-Hua, Shi Ying and Liu Hui-li*
    Abstract View Full Article View
    mendeley

    Effect of a third booster dose of COVID-19 mRNA vaccine in patients with haematological cancer after the initial two-dose vaccination - a single centre report

    DOI Logo 10.17352/jvi.000052

    Published On: August 08, 2022 | Pages: 029 - 032

    Author(s): Šušol Ondrej, Šušolová Barbora and Hájek Roman*
    Abstract View Full Article View
    mendeley

    Adult-onset Still’s disease complicated with macrophage activation syndrome: A case report

    DOI Logo 10.17352/jvi.000051

    Published On: July 23, 2022 | Pages: 023 - 028

    Author(s): MNSK Perera* and A Gunapala
    Abstract View Full Article View    

     

    Clients' voices

    Readmore

    Indexing/Archiving